Mayumi Ono Selected Research

Mayumi Ono Research Topics

Disease

57	Neoplasms (Cancer) 03/2024 - 02/2002
21	Lung Neoplasms (Lung Cancer) 11/2022 - 04/2004
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2004
9	Breast Neoplasms (Breast Cancer) 03/2024 - 12/2005
6	Hepatocellular Carcinoma (Hepatoma) 07/2016 - 12/2005
6	Carcinoma (Carcinomatosis) 10/2013 - 12/2005
5	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2003
4	Carcinogenesis 11/2022 - 04/2004
4	Corneal Neovascularization 12/2007 - 12/2003
3	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 07/2007
3	Adenocarcinoma of Lung 02/2014 - 08/2005
3	Stomach Neoplasms (Stomach Cancer) 05/2013 - 08/2010
3	Hypoxia (Hypoxemia) 09/2010 - 07/2003
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2010 - 06/2006
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2024 - 03/2019
2	Triple Negative Breast Neoplasms 03/2024 - 01/2020
2	Lymphatic Metastasis 11/2023 - 01/2014
2	Inflammation (Inflammations) 11/2023 - 08/2008
2	Weight Gain 01/2015 - 01/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2014 - 10/2013
2	Osteosarcoma (Osteogenic Sarcoma) 09/2010 - 02/2002
2	Melanoma (Melanoma, Malignant) 06/2009 - 09/2004
1	Sepsis (Septicemia) 09/2023
1	Confusion (Bewilderment) 09/2023
1	Human Influenza (Influenza) 07/2022

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2002
20	Gefitinib (Iressa)FDA Link 11/2022 - 05/2002
20	ErbB Receptors (EGF Receptor)IBA 01/2018 - 04/2004
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 03/2002
11	Tyrosine Kinase InhibitorsIBA 01/2018 - 05/2002
10	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017 - 12/2006
6	Phosphotransferases (Kinase)IBA 05/2019 - 06/2009
6	Messenger RNA (mRNA)IBA 04/2014 - 02/2002
5	Transcription Factors (Transcription Factor)IBA 05/2019 - 01/2003
5	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2017 - 03/2002
5	Small Interfering RNA (siRNA)IBA 05/2012 - 03/2008
5	NF-kappa B (NF-kB)IBA 05/2010 - 09/2007
4	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 06/2010
4	Biomarkers (Surrogate Marker)IBA 03/2024 - 09/2009
4	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2014 - 12/2003
4	matrigelIBA 01/2014 - 06/2006
4	CytokinesIBA 08/2013 - 11/2005
4	Fluorouracil (Carac)FDA LinkGeneric 10/2008 - 12/2006
4	Epidermal Growth Factor (EGF)IBA 03/2008 - 02/2002
3	Indicators and Reagents (Reagents)IBA 11/2023 - 01/2008
3	AntibodiesIBA 02/2014 - 06/2010
3	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2013 - 12/2007
3	Trastuzumab (Herceptin)FDA Link 05/2013 - 12/2005
3	Angiogenesis InhibitorsIBA 07/2012 - 04/2004
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2008 - 11/2005
3	Estrogen Receptor alphaIBA 03/2008 - 05/2006
2	Azacitidine (5 Azacytidine)FDA Link 04/2024 - 03/2019
2	NickelIBA 11/2023 - 07/2003
2	CalciumIBA 11/2023 - 09/2010
2	MicroRNAs (MicroRNA)IBA 11/2022 - 12/2011
2	Proto-Oncogene Proteins c-metIBA 11/2022 - 12/2011
2	osimertinibIBA 01/2022 - 09/2017
2	Carrier Proteins (Binding Protein)IBA 01/2020 - 12/2018
2	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2020 - 01/2017
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 05/2019 - 01/2003
2	Growth Factor ReceptorsIBA 05/2019 - 09/2009
2	QuinazolinesIBA 01/2019 - 04/2004
2	AfatinibIBA 09/2017 - 08/2014
2	Everolimus FDA Link 07/2016 - 01/2014
2	Triglycerides (Triacylglycerol)IBA 01/2015 - 01/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 01/2013
2	InterleukinsIBA 01/2014 - 12/2007
2	AntioxidantsIBA 10/2013 - 10/2008
2	PeroxiredoxinsIBA 10/2013 - 10/2008
2	CXC ChemokinesIBA 08/2013 - 05/2010
2	Lapatinib (GW572016)FDA Link 05/2013 - 01/2008
2	Peptides (Polypeptides)IBA 07/2012 - 02/2011
2	Protein Kinase CIBA 12/2011 - 01/2008
2	Threonine (L-Threonine)FDA Link 09/2011 - 05/2010
2	Thymidine PhosphorylaseIBA 08/2010 - 05/2002
2	NF-KappaB Inhibitor alphaIBA 05/2010 - 06/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2009 - 07/2007
2	Thrombospondin 1IBA 10/2008 - 02/2002
2	Liposomes (Liposome)IBA 08/2008 - 12/2007
2	Interleukin-1beta (Interleukin 1 beta)IBA 08/2008 - 11/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2008 - 02/2002
2	ChemokinesIBA 08/2008 - 12/2007
2	Celecoxib (Celebrex)FDA Link 01/2008 - 12/2007
2	LigandsIBA 05/2007 - 12/2005
2	Mitogen-Activated Protein Kinase 3IBA 12/2005 - 04/2004
2	Semaxinib (SU5416)IBA 05/2002 - 03/2002
1	Circulating Tumor DNAIBA 03/2024
1	A-Form DNA (A-DNA)IBA 03/2024
1	beta CateninIBA 11/2023
1	RNA (Ribonucleic Acid)IBA 11/2023
1	Methicillin (Metin)FDA Link 09/2023
1	5'-N-methylcarboxamideadenosineIBA 09/2023
1	CoagulaseIBA 09/2023
1	SilverIBA 07/2022
1	Arginine (L-Arginine)FDA Link 01/2022
1	OrnithineIBA 01/2022

Therapy/Procedure

16	Therapeutics 01/2020 - 01/2003
3	Drug Therapy (Chemotherapy) 02/2009 - 08/2005
2	Oral Administration 01/2019 - 07/2012
2	Aftercare (After-Treatment) 09/2011 - 10/2008